Ads
related to: aldx stock
Search results
Aldeyra (ALDX) Stock Rallies 43% in One Week: Here's Why
Zacks via Yahoo Finance· 4 weeks agoAldeyra (ALDX) rises 43% in one week, driven by plans to initiate a pivotal study to support the...
Can Aldeyra Therapeutics, Inc. (ALDX) Climb 107.66% to Reach the Level Wall Street Analysts Expect?
Zacks via Yahoo Finance· 9 months agoThe mean of analysts' price targets for Aldeyra Therapeutics, Inc. (ALDX) points to a 107.7% upside...
Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year?
Zacks via Yahoo Finance· 2 weeks agoThe Medical group has plenty of great stocks, but investors should always be looking for companies...
Insiders made the right call by buying US$1.2m Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) stock this...
Simply Wall St. via Yahoo Finance· 1 year agoInsiders who bought Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) in the last 12 months may probably not...
Here's Why You Should Invest in Aldeyra (ALDX) Stock Now
Zacks via Yahoo Finance· 2 months agoBurlington, MA-based Aldeyra Therapeutics ALDX is a leader in the development of RASP (reactive...
Biotech Stock Roundup: ALDX, EVLO Down on Setback, SRRK Offers Updates & More
Zacks via Yahoo Finance· 7 months agoIt was a busy week for the biotech sector before the third-quarter earnings kicked in. While nothing...
Aldeyra's (ALDX) Dry Eye Disease Chamber Study Meets Goals
Zacks via Yahoo Finance· 2 years agoAldeyra's (ALDX) vehicle-controlled crossover study evaluating 0.25% reproxalap ophthalmic solution...
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) has caught the attention of institutional investors who...
Simply Wall St. via Yahoo Finance· 8 months agoKey Insights Institutions' substantial holdings in Aldeyra Therapeutics implies that they have...
Owning 40% shares,institutional owners seem interested in Aldeyra Therapeutics, Inc. (NASDAQ:ALDX),
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Institutions' substantial holdings in Aldeyra Therapeutics implies that they have...
Institutions own 37% of Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) shares but retail investors control...
Simply Wall St. via Yahoo Finance· 2 months agoKey Insights Significant control over Aldeyra Therapeutics by retail investors implies that the...
